為全面了解中藥遠(yuǎn)志的研究熱點(diǎn)與發(fā)展趨勢(shì)，收集歷年來(lái)中國(guó)學(xué)術(shù)期刊全文數(shù)據(jù)庫(kù)（CNKI）、萬(wàn)方數(shù)據(jù)庫(kù)（Wanfang Data）、維普生物醫(yī)學(xué)數(shù)據(jù)庫(kù)（VIP）、中國(guó)生物醫(yī)學(xué)文獻(xiàn)數(shù)據(jù)庫(kù)（CBM）、Web of Science（WOS）數(shù)據(jù)庫(kù)、PubMed 數(shù)據(jù)庫(kù)及 Scopus 數(shù)據(jù)庫(kù)醫(yī)學(xué)文獻(xiàn)檢索服務(wù)系統(tǒng)中涉及遠(yuǎn)志研究的 2 687 篇中文文獻(xiàn)和 482 篇英文文獻(xiàn)，利用 VOSviewer進(jìn)行文獻(xiàn)計(jì)量和可視化分析。結(jié)果發(fā)現(xiàn)中文文獻(xiàn)研究熱點(diǎn)為以三萜皂苷類為主的遠(yuǎn)志活性成分和遠(yuǎn)志質(zhì)量評(píng)價(jià)研究、遠(yuǎn)志治療阿爾茨海默病的網(wǎng)絡(luò)藥理學(xué)及作用機(jī)制、遠(yuǎn)志及其復(fù)方臨床治療用藥規(guī)律的數(shù)據(jù)挖掘研究；英文文獻(xiàn)研究熱點(diǎn)為遠(yuǎn)志治療阿爾茨海默病的有效活性成分及其藥理作用機(jī)制研究。

In order to comprehensively understand the research hotspots and development trends of Chinese traditional medicine Polygalae Radix. This study collected 2 687 Chinese literatures and 482 English literatures related to Polygala tenuifolia Willd. and P. sibirica L. research in the core collection databases of China Academic Journal Full-text Database (CNKI), Wanfang Database (Wanfang Data ), VIP Biomedical Database (VIP), China Biomedical Literature Database (CBM), Web of Science (WOS) database, PubMed database and Scopus medical literature retrieval service system over the years, and conducted bibliometric and visual analysis using VOS viewer. The results showed that the hotspots of Chinese literature research were the study of active components of Polygalae Radix, mainly triterpenoid saponins, the study of quality evaluation of Polygalae Radix, the study of network pharmacology and action mechanism of Polygalae Radix in the treatment of Alzheimer's disease, and the study of data mining on the rule of drug for clinical symptoms of Polygalae Radix and its compound. The hotspot of English literature research was the effective components and pharmacological mechanism of Polygalae Radix in the treatment of Alzheimer's disease.

R284.1；R285.5

陜西省自然科學(xué)基礎(chǔ)研究計(jì)劃項(xiàng)目（2021JQ-922）；陜西省中醫(yī)藥管理局“秦藥”開(kāi)發(fā)重點(diǎn)科學(xué)研究項(xiàng)目（2021-02-ZZ-002）；陜西省中醫(yī)藥管理局中醫(yī)藥全省性專款專項(xiàng)項(xiàng)目（2021-QYZL-01）；陜西省重點(diǎn)研發(fā)計(jì)劃項(xiàng)目（2023-YBSF-471/491）